Daniel J Siegwart

This inventor holds 21 USPTO granted patents and 25 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: The University of Texas System, Invivo Therapeutics Corporation, Massachusetts Institute of Technology. Active years: 2016-2025.

USPTO Granted Patents = 21 (Patent Applications = 25)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 32)

EPO Patents = 3 (Patent Applications = 33)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 45(Granted Patents)

Location History:

Cambridge, MA (US) (2018)
Dallas, TX (US) (2016 - 2024)

Company Filing History:

20 out of 5,627

The University of Texas System

patents

1 out of 1

Invivo Therapeutics Corporation

patent

1 out of 8,573

Massachusetts Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357580 - Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids (2025-07-15),

2. 12252464 - Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids (2025-03-18),

3. 12133924 - Compositions and methods for organ specific delivery of nucleic acids (2024-11-05),

4. 12104181 - Compositions and methods for treating viral infections targeting TRIM7 (2024-10-01),

5. 12024486 - Lipocationic dendrimers and uses thereof (2024-07-02),

6. 11999683 - Lipocationic dendrimers and uses thereof (2024-06-04),

7. 11858884 - Compositions and methods for modulating gene or gene product in cells (2024-01-02),

8. 11766408 - Compositions and methods for organ specific delivery of nucleic acids (2023-09-26),

9. 11685710 - Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids (2023-06-27),

10. 11648210 - Compositions and methods for organ specific delivery of nucleic acids (2023-05-16),

11. 11648209 - Compositions and methods for organ specific delivery of nucleic acids (2023-05-16),

12. 11590085 - Compositions and methods for organ specific delivery of nucleic acids (2023-02-28),

13. 11542229 - Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids (2023-01-03),

14. 11510880 - Compositions and methods for organ specific delivery of nucleic acids (2022-11-29),

15. 11304911 - Compositions and methods for organ specific delivery of nucleic acids (2022-04-19),

Title: Daniel J Siegwart: Pioneering Inventor from Dallas, TX

Introduction: Daniel J Siegwart is a renowned inventor based in Dallas, Texas, known for his groundbreaking contributions to the field of biotechnology and drug delivery systems.

Latest Patents: Daniel J Siegwart holds several patents related to innovative drug delivery mechanisms and nanomedicine technologies, revolutionizing the way medications are administered and enhancing their efficacy.

Career Highlights: With a background in chemical engineering and a Ph.D. in Biomedical Engineering, Siegwart has had a successful career marked by numerous accolades and awards for his pioneering work in the healthcare industry.

Collaborations: Throughout his career, Daniel J Siegwart has collaborated with leading pharmaceutical companies, research institutions, and universities to further develop and commercialize his inventions, making a significant impact on the medical field.

Conclusion: Daniel J Siegwart's relentless pursuit of innovation and his dedication to improving drug delivery systems have solidified his reputation as a trailblazer in the field of biotechnology, with his work continuing to inspire advancements in healthcare worldwide.